- Home
- MTLS vs TRDA Comparison
MTLS vs TRDA Comparison
Compare MTLS & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- TRDA
- Stock Information
- Founded
- MTLS 1990
- TRDA 2016
- Country
- MTLS Belgium
- TRDA United States
- Employees
- MTLS N/A
- TRDA N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- TRDA Health Care
- Exchange
- MTLS Nasdaq
- TRDA Nasdaq
- Market Cap
- MTLS 316.0M
- TRDA 301.0M
- IPO Year
- MTLS 2014
- TRDA 2021
- Fundamental
- Price
- MTLS $5.40
- TRDA $7.12
- Analyst Decision
- MTLS
- TRDA Strong Buy
- Analyst Count
- MTLS 0
- TRDA 3
- Target Price
- MTLS N/A
- TRDA $25.67
- AVG Volume (30 Days)
- MTLS 86.5K
- TRDA 126.5K
- Earning Date
- MTLS 07-30-2025
- TRDA 08-12-2025
- Dividend Yield
- MTLS N/A
- TRDA N/A
- EPS Growth
- MTLS 43.31
- TRDA N/A
- EPS
- MTLS 0.17
- TRDA 0.61
- Revenue
- MTLS $291,295,936.00
- TRDA $172,220,000.00
- Revenue This Year
- MTLS $6.42
- TRDA N/A
- Revenue Next Year
- MTLS $8.33
- TRDA N/A
- P/E Ratio
- MTLS $32.22
- TRDA $11.70
- Revenue Growth
- MTLS 6.16
- TRDA 5.74
- 52 Week Low
- MTLS $3.93
- TRDA $6.94
- 52 Week High
- MTLS $9.69
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- MTLS 51.84
- TRDA 36.18
- Support Level
- MTLS $5.37
- TRDA $6.94
- Resistance Level
- MTLS $5.65
- TRDA $8.49
- Average True Range (ATR)
- MTLS 0.18
- TRDA 0.42
- MACD
- MTLS -0.02
- TRDA -0.07
- Stochastic Oscillator
- MTLS 34.27
- TRDA 10.91
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.